| |
Positive Treatment Response of Pritelivir Achieved in Refractory Herpes Simplex Virus Infections in Immunocompromised Patients, Including Haematopoietic Cell and Solid Organ Transplant Recipients, and Oncology Patients: PRIOH-1 Phase 3 Trial
|
| |
| |
Positive Treatment Response of Pritelivir Achieved in Refractory Herpes Simplex Virus Infections in Immunocompromised Patients, Including Haematopoietic Cell and Solid Organ Transplant Recipients, and Oncology Patients: PRIOH-1 Phase 3 Trial
|
|
| |
| |
|
|
|
